Reneubio

ReneuBio Inc. is dedicated to revolutionizing therapeutic approaches for age-related neurological injuries and diseases, such as stroke recovery and Alzheimer’s disease. Our mission is to develop breakthrough medicines that activate dormant neural stem cells in the aging brain, catalyzing resilience, regeneration, and recovery. At our core is a validated first-in-class Target Discovery Engine allowing us to rapidly and scalably identify therapeutic targets directly in aged tissues. Leveraging our Discovery Engine, we are actively building a robust portfolio of therapeutic assets with our lead program being a genetically validated in vivo target that boosts regeneration in the old brain. We aim to significantly improve the treatment of age-related neurological disorders, offering patients enhanced treatment options and improved disease outcomes. While initially concentrating on treating devastating neurological conditions, ReneuBio's broader vision is to help people live healthier longer.